Key Takeaway: The article features Skye's Chief Medical Officer, Puneet Arora, discussing the negative impacts of excess energy storage in the body, particularly how it contributes to obesity and related health issues. The focus is on the detrimental effects of deranged metabolism and the need for awareness in addressing these conditions. The insights aim to foster a better understanding of metabolic health.
Price reaction · baseline $4.25 (2025-09-12 close) · 3 other SKYE headline(s) in the window, move may be shared
day 0 close · peak
-4.2%
Market Sentiment Analysis
POSITIVE FACTORS
Highlights the importance of understanding metabolism.
Raises awareness about obesity and its health implications.
Encourages discussions on metabolic health.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+84%
120-day peak, hindsight
Typical move
24.3%
average across 4 past catalysts
Cash runway
~4 mo
High dilution risk
Lead asset
Nimacimab
Phase 2 · Obesity
Full Press Release Details
All
Primers
Perspectives
Progress
Press
The Detriment of Deranged Metabolism
Date published:
September 13, 2025 2:54 pm PDT
Share
Skye Chief Medical Officer, Puneet Arora, MD, MS, FACE, discusses how excess energy stored by the body’s metabolic system as excess fat leads to obesity and other unhealthy conditions.
Frequently Asked Questions
Who is Puneet Arora?
Puneet Arora is the Chief Medical Officer at Skye.
What does deranged metabolism lead to?
Deranged metabolism can lead to obesity and other unhealthy conditions.
When was the article published?
The article was published on September 13, 2025.
What is the focus of the article?
The article focuses on the effects of excess energy storage in the body.